Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 2

1(14.3%)

7Total

N/A(6)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07536724Not ApplicableNot Yet Recruiting

First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation

Role: collaborator

NCT06552637Not ApplicableRecruiting

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

Role: collaborator

NCT05592392Not ApplicableCompleted

RECOVER-HF Pilot Study of SDS in Heart Failure

Role: collaborator

NCT06700226Not ApplicableCompleted

AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man

Role: collaborator

NCT05440513Not ApplicableUnknown

A Study of Non-Vascular Renal Denervation Using the Verve Medical Phoenix ™ System

Role: collaborator

NCT02771509Phase 2Unknown

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

Role: collaborator

NCT03484780Not ApplicableCompleted

VisONE Heart Failure Study: Pilot

Role: collaborator

All 7 trials loaded